Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endoscopic balloon dilatation with or without triamcinolone injection and Budenofalk in Crohn's anastomotic stenosis
NL-OMON24606Active, not recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- May 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in Crohn's disease comparing Triamcinolone + Budenofalk with Placebo injection + placebo capsules (2 arms). Primary endpoint: Recurrence of stenosis and/or need for surgical intervention. Started May 2009; status: active, not recruiting.
02
Drugs
budesonidetriamcinolone
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NL-OMON24606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24606.